Volume 1, Issue 3 pp. 247-255
Research Article
Full Access

Identification of a transcriptional unit adjacent to the breakpoint in the 14;19 translocation of chronic lymphocytic leukemia

Timothy W. McKeithan

Corresponding Author

Timothy W. McKeithan

Departments of Pathology and Medicine, University of Chicago, Chicago, Illinois

Department of Pathology, Box 414, University of Chicago, 5841 S. Maryland Ave., Chicago, IL 60637Search for more papers by this author
Hitoshi Ohno

Hitoshi Ohno

Departments of Pathology and Medicine, University of Chicago, Chicago, Illinois

Search for more papers by this author
Manuel O. Diaz

Manuel O. Diaz

Departments of Pathology and Medicine, University of Chicago, Chicago, Illinois

Search for more papers by this author
First published: January 1990
Citations: 53

Abstract

The t(14;19)(q32.3;q13.1) is a recurring translocation found in the neoplastic cells of some patients with chronic lymphocytic leukemia (CLL). We have previously cloned the translocation breakpoint junction present in the leukemic cells from one such patient. In the present study, we have cloned and sequenced the breakpoint junction from a second patient. The breakpoint on chromosome 14 occurs within a switch region upstream of the immunoglobulin heavy chain Cα1 sequence. We detected a 2.1–2.3 kb transcript on Northern blots using a probe from chromosome 19 adjacent to this breakpoint. S1 nuclease protection experiments showed that transcription of the gene proceeds in a direction away from the breakpoint junction. This gene (for which we propose the name BCL3) may contribute to the malignant development of B-lymphocytes following the chromosome translocation. If so, it is the first protooncogene identified whose activation is principally associated with CLL.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.